Kokkali, S.; Kyriazoglou, A.; Mangou, E.; Economopoulou, P.; Panousieris, M.; Psyrri, A.; Ardavanis, A.; Vassos, N.; Boukovinas, I.
Real-World Data on Cabozantinib in Advanced Osteosarcoma and Ewing Sarcoma Patients: A Study from the Hellenic Group of Sarcoma and Rare Cancers. J. Clin. Med. 2023, 12, 1119.
https://doi.org/10.3390/jcm12031119
AMA Style
Kokkali S, Kyriazoglou A, Mangou E, Economopoulou P, Panousieris M, Psyrri A, Ardavanis A, Vassos N, Boukovinas I.
Real-World Data on Cabozantinib in Advanced Osteosarcoma and Ewing Sarcoma Patients: A Study from the Hellenic Group of Sarcoma and Rare Cancers. Journal of Clinical Medicine. 2023; 12(3):1119.
https://doi.org/10.3390/jcm12031119
Chicago/Turabian Style
Kokkali, Stefania, Anastasios Kyriazoglou, Elpida Mangou, Panagiota Economopoulou, Michail Panousieris, Amanda Psyrri, Alexandros Ardavanis, Nikolaos Vassos, and Ioannis Boukovinas.
2023. "Real-World Data on Cabozantinib in Advanced Osteosarcoma and Ewing Sarcoma Patients: A Study from the Hellenic Group of Sarcoma and Rare Cancers" Journal of Clinical Medicine 12, no. 3: 1119.
https://doi.org/10.3390/jcm12031119
APA Style
Kokkali, S., Kyriazoglou, A., Mangou, E., Economopoulou, P., Panousieris, M., Psyrri, A., Ardavanis, A., Vassos, N., & Boukovinas, I.
(2023). Real-World Data on Cabozantinib in Advanced Osteosarcoma and Ewing Sarcoma Patients: A Study from the Hellenic Group of Sarcoma and Rare Cancers. Journal of Clinical Medicine, 12(3), 1119.
https://doi.org/10.3390/jcm12031119
